Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 3,421,078 $ 864,840
Prepaid expenses and other current assets 448,033 607,670
Total current assets 3,869,111 1,472,510
Total assets 3,869,111 1,472,510
Current liabilities:    
Accounts payable and accrued expenses 1,177,038 1,355,867
Short-term notes payable, net of debt issuance costs 2,554,385 328,528
Total liabilities 3,731,423 1,684,395
Shareholders’ equity (deficit):    
Preferred stock, no par value; 50,000,000 shares authorized; 7,488,692 and 7,488,692 Series F shares and 1,000,000 and -0- Series G outstanding at March 31, 2025 and December 31, 2024, respectively
Common stock, $0.001 par value; 350,000,000 shares authorized and 21,475,289 and 12,570,100 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 21,475 12,570
Additional paid-in capital 219,119,378 216,561,717
Accumulated deficit (219,003,165) (216,786,172)
Total shareholders’ equity (deficit) 137,688 (211,885)
Total liabilities and shareholders’ equity (deficit) $ 3,869,111 $ 1,472,510